Wall Street Breakfast Wegovy patients maintain weight loss over four years
May 14, 2024
Patients on Wegovy maintain impressive weight loss over four years, while Walmart plans to cut corporate jobs and Uber buys foodpanda in Taiwan for $950M. The podcast also covers significant stock movers, CPI inflation data, and insights on consumer downshift from Morgan Stanley.
AI Snips
Chapters
Transcript
Episode notes
Wegovy Sustains Weight Loss Long-Term
- Patients using Novo Nordisk's Wegovy have maintained an average of 10% weight loss over four years.
- This long-term study shows semaglutide's effectiveness, aiding coverage discussions with insurers and governments.
Wegovy Offers Cardiovascular Benefits
- Wegovy demonstrated cardiovascular benefits across diverse patient groups regardless of demographics or obesity levels.
- This broad benefit strengthens the drug's value proposition beyond weight loss.
Walmart Cuts Jobs, Limits Remote Work
- Walmart plans to cut hundreds of corporate jobs and relocate workers to major hubs.
- Remote work is being limited, requiring employees to be onsite most of the time.